Company: HURA
Filing Date: 2025-03-31
Form Type: 10-K
Source: 0000950170-25-047921
Chunk: 181

Company: TuHURA Biosciences, Inc./NV
Filing Date: 2025-03-31
Form: 10-K
Item: Item 1A
Chunk 181
---
 brokerage firms will want to conduct any follow-on offerings on our behalf in the future.

We do not anticipate that we will pay any cash dividends in the foreseeable future.

The current expectation is that we will retain our future earnings, if any, to fund the growth of our business as opposed to paying dividends. As a result, capital appreciation, if any, of our common stock will be our stockholders’ sole source of gain for the foreseeable future.

Risks Related to the Kineta Merger

Failure to complete the Kineta Merger could negatively impact our stock price, future business and financial results. 

Our obligation to complete the Kineta Merger is subject to the satisfaction or waiver of a number of conditions set forth in the Kineta Merger Agreement. There can be no assurance that the conditions to completion of the Kineta Merger will be satisfied or waived or that the Kineta Merger will be completed. If the Kineta Merger is not completed for any reason, our ongoing businesses may be materially and adversely affected and, without realizing any of the benefits of having completed the Kineta Merger, we would be subject to a number of risks, including the following: 

•we may experience negative reactions from the financial markets, including negative impacts on the trading price of our common stock, which could affect our ability to secure sufficient financing in the future on attractive terms (or at all) as a standalone company, and from our customers, vendors, regulators and employees; 

•we may be required to pay a termination fee of $1 million if we fail to consummate the Kineta Merger under specified circumstances; 

•we will be required to pay certain expenses incurred in connection with the Kineta Merger, whether or not the Kineta Merger is completed; and 

•matters relating to the Kineta Merger (including integration planning) will require substantial commitments of time and resources by our management and the expenditure of significant funds in the form of fees and expenses, which would otherwise have been devoted to day-to-day operations and other opportunities that may have been beneficial to our company. 

In addition, we could be subject to litigation related to any failure to complete the Merger or related to any proceeding to specifically enforce our obligations under the Merger Agreement. 

If any of these risks materialize, they may materially and adversely affect our business, financial condition, financial results and stock prices. 

The market price of our common stock will continue to fluctuate after the Kineta Merger.

Upon completion of the Kineta